Medication reconciliation effect on prolonged inpatient stress ulcer prophylaxis.
BACKGROUND
While medication reconciliation (MR) has been shown to reduce medication errors by limiting errors of transcription, omission, and duplicate therapy, its impact on the provision of unnecessary prophylaxis is largely unknown.


OBJECTIVE
To determine the effect of MR on the incidence of prolonged stress ulcer prophylaxis (SUP) across the continuum of care from hospital admission to discharge as well as evaluate clinical conditions associated with prolonged SUP.


METHODS
This retrospective study assessed patients who were admitted to the intensive care unit (ICU) and had SUP initiated. Patients were excluded if they were receiving gastroprotective therapy prior to ICU admission, were being treated for an acute gastrointestinal hemorrhage, or died. The need for SUP was determined using risk factors adapted from evidence-based guidelines developed by the American Society of Health-System Pharmacists. The use of SUP was assessed upon transfer from the ICU to a non-ICU setting and at hospital discharge. Results were compared between pre-MR and post-MR groups.


RESULTS
Data from 114 (pre-MR, n = 53; post-MR, n = 61) medical and surgical ICU patients were evaluated. There was no significant difference in the use of prolonged SUP upon transfer from the ICU to a non-ICU setting in the pre-MR and post-MR groups, respectively (85% [45/53] vs 79% [48/61], p = 0.393). Similarly, there was no significant difference in the use of prolonged SUP upon hospital discharge in the pre-MR and post-MR groups, respectively (14% [6/44] vs 23% [10/43], p = 0.247). There were no clinical conditions for which prolonged SUP use was predominant.


CONCLUSIONS
The strategy of MR alone will not decrease the incidence of prolonged SUP in hospitalized patients. Other techniques should be evaluated to encourage appropriate use of acid-suppressive agents.
Zeigler
Amy J
AJ
Central Michigan Community Hospital, Mt Pleasant, MI, USA.
McAllen
Karen J
KJ
Slot
Martha G
MG
Barletta
Jeffrey F
JF
D000328:Adult; D000368:Aged; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D003266:Continuity of Patient Care; D004363:Drug Utilization; D006764:Hospitals, Community; D006784:Hospitals, Teaching; D006801:Humans; D007297:Inpatients; D007362:Intensive Care Units; D008824:Michigan; D008875:Middle Aged; D010343:Patient Admission; D010351:Patient Discharge; D010360:Patient Transfer; D012189:Retrospective Studies; D012307:Risk Factors; D013276:Stomach Ulcer / Q000517:prevention & control*; D013315:Stress, Psychological / Q000517:prevention & control*
D000897:Anti-Ulcer Agents